The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck

Illumina Inc., a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly owned subsidiary of VUMC, today announced the five founding members of the Alliance for Genomic Discovery.

Verily Launches AI-Powered Chronic Care Solution, Lightpath

What You Should Know: – Verily, Alphabet’s precision health subsidiary, today announced Lightpath, a next-generation chronic care solution designed to address the evolving needs of

June 12, 2024

BioNTech grabs PD-L1/VEGF bispecific with $55M upfront, expanding pipeline while lowering Covid guidance

As BioNTech continues to beef up its oncology pipeline, it’s once again turning to a Chinese partner. The German biotech is putting down $55 million

November 7, 2023

PreciseDx Raises $20.7M for AI-Powered Cancer Risk Assessments

What You Should Know: – PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide

August 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.